Singapore pledges $1.27m to global vaccine alliance

This follows previous support, including a $6.4m (US$5m) donation in 2020.

Singapore has contributed $1.27m (US$1m) to Gavi, the Vaccine Alliance, in support of global immunisation efforts, according to the Ministry of Health.

The contribution follows previous support, including a $6.4m (US$5m) donation in 2020 to the Gavi COVAX Advance Market Commitment and the donation of 1.6 million COVID-19 vaccine doses through the COVAX Facility in 2021.

“Vaccines are one of the most effective tools in preventing diseases and saving lives. However, millions of people around the world still lack access to essential vaccines,” the ministry said.

Meanwhile, Gavi collaborates with governments, international organisations, and private sector partners to support vaccine delivery and improve immunisation systems, it added.

US$1 = $1.27

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia